Sage slashes half its workforce in rejig targeting Zulresso commercial team

8th April 2020 Uncategorised 0

Sage Therapeutics cut more than half of its workforce in a restructuring move that slams postpartum drug Zulresso. The 53% laid off—an estimated 340 employees—primarily worked in commercial operations for Zulresso, an IV drug with a 60-hour infusion time.

More: Sage slashes half its workforce in rejig targeting Zulresso commercial team
Source: fierce